نتائج البحث

1

دورية أكاديمية

Corrigendum: Time interval from diagnosis to treatment of brain metastases with stereotactic radiosurgery is not associated with radionecrosis or local failure

المؤلفون: Justin Leu, Meredith Akerman, Christopher Mendez, Jonathan W. Lischalk, Todd Carpenter, David Ebling, Jonathan A. Haas, Matthew Witten, Marissa Barbaro, Paul Duic, Lee Tessler, Michael C. Repka

المصدر: Frontiers in Oncology, Vol 13 (2023)

مصطلحات موضوعية: stereotactic radiosurgery, brain metastases, immunotherapy, radionecrosis, treatment delays, cancer, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

العلاقة: https://www.frontiersin.org/articles/10.3389/fonc.2023.1192726/fullTest; https://doaj.org/toc/2234-943XTest

الوصول الحر: https://doaj.org/article/b6f8c241b60643f08e07c8c49fbc0fecTest

View record in DOAJ

النص الكامل

2

دورية أكاديمية

Time interval from diagnosis to treatment of brain metastases with stereotactic radiosurgery is not associated with radionecrosis or local failure

المؤلفون: Justin Leu, Meredith Akerman, Christopher Mendez, Jonathan W. Lischalk, Todd Carpenter, David Ebling, Jonathan A. Haas, Matthew Witten, Marissa Barbaro, Paul Duic, Lee Tessler, Michael C. Repka

المصدر: Frontiers in Oncology, Vol 13 (2023)

مصطلحات موضوعية: stereotactic radiosurgery, brain metastases, immunotherapy, radionecrosis, treatment delays, cancer, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

العلاقة: https://www.frontiersin.org/articles/10.3389/fonc.2023.1132777/fullTest; https://doaj.org/toc/2234-943XTest

الوصول الحر: https://doaj.org/article/3320c9ff6e714a2ea7a7c7e5157bd4e3Test

View record in DOAJ

النص الكامل

3

دورية أكاديمية

First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma

المؤلفون: Linda M. Liau, Keyoumars Ashkan, David D. Tran, Jian L. Campian, John E. Trusheim, Charles S. Cobbs, Jason A. Heth, Michael Salacz, Sarah Taylor, Stacy D. D’Andre, Fabio M. Iwamoto, Edward J. Dropcho, Yaron A. Moshel, Kevin A. Walter, Clement P. Pillainayagam, Robert Aiken, Rekha Chaudhary, Samuel A. Goldlust, Daniela A. Bota, Paul Duic, Jai Grewal, Heinrich Elinzano, Steven A. Toms, Kevin O. Lillehei, Tom Mikkelsen, Tobias Walbert, Steven R. Abram, Andrew J. Brenner, Steven Brem, Matthew G. Ewend, Simon Khagi, Jana Portnow, Lyndon J. Kim, William G. Loudon, Reid C. Thompson, David E. Avigan, Karen L. Fink, Francois J. Geoffroy, Scott Lindhorst, Jose Lutzky, Andrew E. Sloan, Gabriele Schackert, Dietmar Krex, Hans-Jorg Meisel, Julian Wu, Raphael P. Davis, Christopher Duma, Arnold B. Etame, David Mathieu, Santosh Kesari, David Piccioni, Manfred Westphal, David S. Baskin, Pamela Z. New, Michel Lacroix, Sven-Axel May, Timothy J. Pluard, Victor Tse, Richard M. Green, John L. Villano, Michael Pearlman, Kevin Petrecca, Michael Schulder, Lynne P. Taylor, Anthony E. Maida, Robert M. Prins, Timothy F. Cloughesy, Paul Mulholland, Marnix L. Bosch

المصدر: Journal of Translational Medicine, Vol 16, Iss 1, Pp 1-9 (2018)

مصطلحات موضوعية: Glioblastoma, Immunotherapy, Dendritic cell, Vaccine, Medicine

وصف الملف: electronic resource

العلاقة: http://link.springer.com/article/10.1186/s12967-018-1507-6Test; https://doaj.org/toc/1479-5876Test

الوصول الحر: https://doaj.org/article/7b4a8b2c7d344b0e9344d197a7338b0aTest

View record in DOAJ

النص الكامل

4

دورية أكاديمية

Correction to: First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma

المؤلفون: Linda M. Liau, Keyoumars Ashkan, David D. Tran, Jian L. Campian, John E. Trusheim, Charles S. Cobbs, Jason A. Heth, Michael Salacz, Sarah Taylor, Stacy D. D’Andre, Fabio M. Iwamoto, Edward J. Dropcho, Yaron A. Moshel, Kevin A. Walter, Clement P. Pillainayagam, Robert Aiken, Rekha Chaudhary, Samuel A. Goldlust, Daniela A. Bota, Paul Duic, Jai Grewal, Heinrich Elinzano, Steven A. Toms, Kevin O. Lillehei, Tom Mikkelsen, Tobias Walbert, Steven R. Abram, Andrew J. Brenner, Steven Brem, Matthew G. Ewend, Simon Khagi, Jana Portnow, Lyndon J. Kim, William G. Loudon, Reid C. Thompson, David E. Avigan, Karen L. Fink, Francois J. Geoffroy, Scott Lindhorst, Jose Lutzky, Andrew E. Sloan, Gabriele Schackert, Dietmar Krex, Hans-Jorg Meisel, Julian Wu, Raphael P. Davis, Christopher Duma, Arnold B. Etame, David Mathieu, Santosh Kesari, David Piccioni, Manfred Westphal, David S. Baskin, Pamela Z. New, Michel Lacroix, Sven-Axel May, Timothy J. Pluard, Victor Tse, Richard M. Green, John L. Villano, Michael Pearlman, Kevin Petrecca, Michael Schulder, Lynne P. Taylor, Anthony E. Maida, Robert M. Prins, Timothy F. Cloughesy, Paul Mulholland, Marnix L. Bosch

المصدر: Journal of Translational Medicine, Vol 16, Iss 1, Pp 1-2 (2018)

مصطلحات موضوعية: Medicine

وصف الملف: electronic resource

العلاقة: http://link.springer.com/article/10.1186/s12967-018-1552-1Test; https://doaj.org/toc/1479-5876Test

الوصول الحر: https://doaj.org/article/523386e861dd4740aa938b4e7fa9768cTest

View record in DOAJ

النص الكامل

5

دورية أكاديمية

An expanded safety/feasibility study of the EMulate Therapeutics Voyager™ System in patients with recurrent glioblastoma

المؤلفون: Garni Barkhoudarian, Michael Badruddoja, Nicholas Blondin, Sajeel Chowdhary, Charles Cobbs, Julius Paul Duic, John Paul Flores, Ekokobe Fonkem, Edward McClay, Louis Burt Nabors, Michael Salacz, Lynn Taylor, Brian Vaillant, Jaya Gill, Santosh Kesari

المصدر: CNS Oncology, Vol 12, Iss 3 (2023)

مصطلحات موضوعية: brain tumor, clinical trial, electromagnetic field, GBM, medical device, novel therapy, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

العلاقة: https://doaj.org/toc/2045-0907Test; https://doaj.org/toc/2045-0915Test; https://doaj.org/article/0926388dd46840d7b67cdd3a03d7b358Test

الإتاحة: https://doi.org/10.2217/cns-2022-0016Test
https://doaj.org/article/0926388dd46840d7b67cdd3a03d7b358Test

View record in BASE

النص الكامل

6

Figure A3 from Rindopepimut with Bevacizumab for Patients with Relapsed EGFRvIII-Expressing Glioblastoma (ReACT): Results of a Double-Blind Randomized Phase II Trial

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e5523b850e66966a71fc3a40a27da45Test
https://doi.org/10.1158/1078-0432.22473939Test

7

Data from A Phase I Trial of Enzastaurin in Patients with Recurrent Gliomas

المؤلفون: Howard A. Fine, Paul S. Albert, Donald Thornton, Luna Musib, Jennifer Walling, Svetlana Kotliarova, Paul Duic, Kraig Moore, Lyndon Kim, Teri N. Kreisl

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ba66e5356279b08adfdf4e1a9ed74d9Test
https://doi.org/10.1158/1078-0432.c.6516834.v1Test

8

Supplementary Data from Rindopepimut with Bevacizumab for Patients with Relapsed EGFRvIII-Expressing Glioblastoma (ReACT): Results of a Double-Blind Randomized Phase II Trial

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f78b399144b94b4e4ba8ee0ccc969b4Test
https://doi.org/10.1158/1078-0432.22473936.v1Test

9

Data from Rindopepimut with Bevacizumab for Patients with Relapsed EGFRvIII-Expressing Glioblastoma (ReACT): Results of a Double-Blind Randomized Phase II Trial

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1db99d990206b480a8975605cdc812acTest
https://doi.org/10.1158/1078-0432.c.6528645.v1Test

10

Supplementary Data from A Phase I Trial of Enzastaurin in Patients with Recurrent Gliomas

المؤلفون: Howard A. Fine, Paul S. Albert, Donald Thornton, Luna Musib, Jennifer Walling, Svetlana Kotliarova, Paul Duic, Kraig Moore, Lyndon Kim, Teri N. Kreisl

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c59f4e7215f8bdd11cdb99ee355a3abTest
https://doi.org/10.1158/1078-0432.22439349.v1Test

تنقيح النتائج